IRIS
ROSELLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 59.129
AS - Asia 5.909
EU - Europa 4.960
SA - Sud America 1.022
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 11
Totale 71.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 58.974
SG - Singapore 3.206
CN - Cina 1.119
BR - Brasile 864
DE - Germania 844
IT - Italia 841
UA - Ucraina 765
IE - Irlanda 634
HK - Hong Kong 577
RU - Federazione Russa 392
VN - Vietnam 294
GB - Regno Unito 292
FR - Francia 288
KR - Corea 270
PL - Polonia 247
FI - Finlandia 205
SE - Svezia 188
ID - Indonesia 84
CA - Canada 77
NL - Olanda 76
JP - Giappone 69
IN - India 64
AR - Argentina 63
MX - Messico 52
AT - Austria 42
BD - Bangladesh 37
ES - Italia 31
IQ - Iraq 30
BE - Belgio 29
EC - Ecuador 29
ZA - Sudafrica 27
TR - Turchia 24
CZ - Repubblica Ceca 19
EU - Europa 19
CO - Colombia 16
PK - Pakistan 14
TW - Taiwan 14
CL - Cile 13
MA - Marocco 13
AE - Emirati Arabi Uniti 12
PY - Paraguay 12
SA - Arabia Saudita 12
UZ - Uzbekistan 11
AU - Australia 10
GR - Grecia 10
LT - Lituania 10
RO - Romania 10
CH - Svizzera 9
EG - Egitto 9
VE - Venezuela 9
IR - Iran 8
JM - Giamaica 8
KG - Kirghizistan 7
PE - Perù 7
AL - Albania 6
HN - Honduras 6
PH - Filippine 6
TH - Thailandia 6
UY - Uruguay 6
CR - Costa Rica 5
JO - Giordania 5
MY - Malesia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
AZ - Azerbaigian 4
KZ - Kazakistan 4
NO - Norvegia 4
NP - Nepal 4
PT - Portogallo 4
TN - Tunisia 4
BG - Bulgaria 3
DZ - Algeria 3
KE - Kenya 3
OM - Oman 3
QA - Qatar 3
RS - Serbia 3
A1 - Anonimo 2
BZ - Belize 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SI - Slovenia 2
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GY - Guiana 1
HU - Ungheria 1
Totale 71.115
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.855
Wilmington 15.436
Houston 14.797
Fairfield 1.669
Singapore 1.387
Ann Arbor 1.013
Ashburn 1.012
Chandler 831
Seattle 690
Jacksonville 682
Cambridge 631
Hong Kong 569
Dublin 568
Beijing 504
Medford 429
Rome 324
Santa Clara 291
Dearborn 287
New York 257
The Dalles 226
Kraków 215
Lawrence 199
Los Angeles 175
Dallas 156
Buffalo 144
San Diego 137
Menlo Park 122
Ho Chi Minh City 107
Zhengzhou 96
Moscow 91
Chicago 78
São Paulo 77
Engelhard 73
Milan 71
Council Bluffs 68
Hanoi 60
Jakarta 60
London 56
Mülheim 56
Nuremberg 51
Saint Petersburg 49
Falls Church 46
Redondo Beach 46
Boardman 45
Nanjing 40
Tokyo 38
Norwalk 37
Phoenix 37
Guangzhou 35
Shanghai 35
Hefei 34
Munich 34
Redwood City 34
Salt Lake City 33
Montreal 30
Brussels 29
Helsinki 29
Warsaw 28
Rio de Janeiro 27
Detroit 26
Mountain View 26
Denver 25
Brooklyn 24
Boston 23
Kunming 23
University Park 23
Columbus 22
Hangzhou 21
Lappeenranta 21
Toronto 21
Verona 21
Orem 20
Palo Alto 20
Belo Horizonte 19
Curitiba 19
San Jose 18
Seoul 18
Tampa 18
Mexico City 17
Dong Ket 16
Elk Grove Village 16
Manchester 16
Nürnberg 16
Stockholm 16
Vienna 16
Frankfurt am Main 15
Johannesburg 15
Amsterdam 14
Brno 14
Chennai 14
Miami 14
Nanchang 14
Porto Alegre 14
Taipei 14
Campinas 13
Guarulhos 13
Poplar 13
San Francisco 13
Turin 13
Brasília 12
Totale 61.962
Salva come PNG Salva come JPEG
Nome #
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 647
Soluble selectin levels in patients with lung cancer 607
Role of serum and glucocorticoid-inducible kinase (SGK)-1 in senescence: a novel molecular target against age-related diseases 522
Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma 513
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer 507
Sex-Genetic Interaction in the Risk for Cerebrovascular Disease 506
Pharmacogenomics and pharmacogenetics of thiazolidinediones: Role in diabetes and cardiovascular risk factors 504
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 478
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 474
Aging: an important risk factor in chemotherapy-associated vascular diseases 462
Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies 462
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 458
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients 456
Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer 455
Minimal sentinel node procedure for staging early breast cancer 454
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study 453
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 453
Pathological classification of DCIS and planning of therapeutic management 452
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass 451
Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice 450
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 449
Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopenia 448
Biological and predictive role of ERCC1 polymorphisms in cancer 448
Effects of conventional therapeutic interventions on the number and function of regulatory T cells 447
Clinical models and biochemical predictors of VTE in lung cancer 445
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 445
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer 445
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy 444
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 442
Day-surgical management of ductal carcinoma in situ (DCIS)of the breast using wide local excision with sentinel node biopsy 441
Immune reaction and colorectal cancer: friends or foes? 440
Adjuvant chemotherapy for stage IB non-small cell lung cancer 439
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 439
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy 439
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 439
Sentinel lymphadenectomy in cutaneous melanoma 438
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy 437
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 437
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 436
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 435
Cardiac surgery with extracorporeal circulation in cancer patients: risk factors for late survival and cancer-related event-free survival 434
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 433
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 433
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer 431
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 431
Prognostic value of glycated hemoglobin in colorectal cancer 431
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 430
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 430
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer 429
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 427
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101) 424
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy 423
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 423
Thromboembolic events in patients treated with anti-angiogenic drugs 420
Monoclonal antibodies in gastrointestinal cancers 420
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer 420
Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' 419
Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience 417
Family history of cancer in patients with gastric cancer 416
Chemoprevention of colonic cancer: is there a foreseeable future? 414
Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients 413
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 413
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 411
Determinants of homocysteine levels in colorectal and breast cancer patients 410
The value of soluble selectin levels in the management of lung cancer patients 410
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: Pros and cons 408
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 407
Prognostic value of soluble P-selectin levels in colorectal cancer 406
Insulinemia and the risk of breast cancer and its relapse 405
Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer 404
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study 403
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis 403
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer 402
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients 402
VEGF and VTE risk in cancer patients-letter 402
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 402
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer 400
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients 399
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience 399
Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients 399
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 399
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study 398
Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis 397
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice 397
Percutaneous cryoablation and vertebroplasty: a case report 396
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 395
[Ductal carcinoma in situ (DCIS): an always present reality; which treatment? Role of sentinel lymph node] 393
CD26: a multi-purpose pharmacological target 393
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 392
In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts 392
Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer 391
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 390
Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes 388
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 388
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy 387
Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer 386
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation 386
Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia 384
Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet 383
Predictive value of high-density lipoprotein (HDL)-cholesterol for cancer-associated venous thromboembolism during chemotherapy 381
Totale 43.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.363 0 0 0 0 0 1.148 1.373 992 222 187 351 90
2021/20222.273 108 237 84 103 98 178 199 178 139 256 165 528
2022/20232.392 261 198 55 264 232 588 204 150 183 28 162 67
2023/20241.035 106 34 59 40 93 237 154 47 22 32 7 204
2024/20255.794 164 1.229 550 300 120 333 405 272 548 566 783 524
2025/20264.005 674 470 1.113 683 815 250 0 0 0 0 0 0
Totale 71.825